• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Venture Capital

Fierce Fundraising Tracker image 2025
Biotech

Fierce Biotech Fundraising Tracker: Haya, NewLimit & more

Welcome to Fierce Biotech's Fundraising Tracker for 2025.
Gabrielle Masson , Darren Incorvaia May 8, 2025 8:50am
dollar sign with colored arrows in a maze

Vivo Capital secures $740M to invest in biotechs

May 7, 2025 4:59pm
declining money logos to indicate losing money

Biopharma VC dropped 20% in Q1 compared to ’24: GlobalData

Apr 30, 2025 12:33pm
abstract black agate background with golden veins fake painted artificial stone marble texture

Versant unveils new autoimmune biotech with $100M fundraise

Apr 24, 2025 8:00am
Business person contemplating how to navigate a maze made of money

Third Rock-backed Merida unveils with $121M for autoimmune plans

Apr 8, 2025 11:03am
dollar sign with colored arrows in a maze

Cell therapy biotech bags $102M to fund phase 3 epilepsy plans

Apr 3, 2025 1:22pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings